As of 2025-07-03, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (22.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -1797.7%.
The range of the Relative Valuation is (21.04) - (24.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.1x - 28.6x | 24.8x |
| Forward P/E multiples | 21.9x - 25.3x | 23.3x |
| Fair Price | (21.04) - (24.11) | (22.92) |
| Upside | -1658.6% - -1885.9% | -1797.7% |
| Date | P/E |
| 2025-07-02 | -1.45 |
| 2025-07-01 | -1.39 |
| 2025-06-30 | -1.36 |
| 2025-06-27 | -1.30 |
| 2025-06-26 | -1.40 |
| 2025-06-25 | -1.34 |
| 2025-06-24 | -1.31 |
| 2025-06-23 | -1.35 |
| 2025-06-20 | -1.32 |
| 2025-06-18 | -1.36 |
| 2025-06-17 | -1.31 |
| 2025-06-16 | -1.33 |
| 2025-06-13 | -1.29 |
| 2025-06-12 | -1.32 |
| 2025-06-11 | -1.39 |
| 2025-06-10 | -1.40 |
| 2025-06-09 | -1.18 |
| 2025-06-06 | -1.22 |
| 2025-06-05 | -1.20 |
| 2025-06-04 | -1.22 |
| 2025-06-03 | -1.20 |
| 2025-06-02 | -1.31 |
| 2025-05-30 | -1.31 |
| 2025-05-29 | -1.30 |
| 2025-05-28 | -1.28 |
| 2025-05-27 | -1.33 |
| 2025-05-23 | -1.32 |
| 2025-05-22 | -1.36 |
| 2025-05-21 | -1.36 |
| 2025-05-20 | -1.11 |
| 2025-05-19 | -1.10 |
| 2025-05-16 | -1.08 |
| 2025-05-15 | -1.05 |
| 2025-05-14 | -0.99 |
| 2025-05-13 | -1.07 |
| 2025-05-12 | -1.22 |
| 2025-05-09 | -1.15 |
| 2025-05-08 | -1.20 |
| 2025-05-07 | -1.18 |
| 2025-05-06 | -1.19 |
| 2025-05-05 | -1.31 |
| 2025-05-02 | -1.28 |
| 2025-05-01 | -1.27 |
| 2025-04-30 | -1.26 |
| 2025-04-29 | -1.33 |
| 2025-04-28 | -1.37 |
| 2025-04-25 | -1.36 |
| 2025-04-24 | -1.33 |
| 2025-04-23 | -1.33 |
| 2025-04-22 | -1.23 |